返回 Agenda
Maximizing Success in Partner Collaborations
Session Chair(s)
Shann Williams, PMP
Senior Director, Operations
Rho, United States
Clinical research is an inherently collaborative enterprise, but competing objectives and priorities between stakeholders (e.g., CROs, government sponsors, pharmaceutical companies, research sites) can hinder innovation and progress within the industry. Being responsive to stakeholder’s needs is critical to research success, but how do we make progress when priorities seem to conflict with each other? Careful planning and strategic focus are imperative to successfully negotiate the needs of all stakeholders. This session will explore how this can be achieved using case studies from three different types of organizations.
Learning Objective : Identify the perspectives and priorities of different clinical research entities, including CROs, government sponsors, voluntary health organizations, and pharmaceutical companies; Describe challenges resulting from these differences and identify potential solutions; Discuss success factors for implementing solutions to collaboration challenges across different clinical research entities.
Speaker(s)
Competing or Complementary Demands? How Seemingly Opposing Needs From Government and Pharmaceutical Clients Created Cohesion.
Shann Williams, PMP
Rho, United States
Senior Director, Operations
Beat AML: A Ground Breaking Master Trial Run by a Consortium of AROs, Global Drug Companies, CRO, and eClinical Vendors
Len Rosenberg, PHD, RPH
Beat AML, A Division of Blood Cancer United, United States
Head of Clinical Operations
The Execution Evolution: Exploring the Untapped Value in Medical Device CRO Partnerships
Charles Raymond, MBA
ICON, plc., United States
Manager, Commercial Affairs